ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NKTR Nektar Therapeutics

1.7908
0.1908 (11.93%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,360,209
Bid Price 1.79
Ask Price 1.85
News -
Day High 1.87

Low
0.4126

52 Week Range

High
1.87

Day Low 1.63
Company Name Stock Ticker Symbol Market Type
Nektar Therapeutics NKTR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1908 11.93% 1.7908 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.65 1.63 1.87 1.76 1.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,519 2,360,209 $ 1.76 $ 4,165,633 - 0.4126 - 1.87
Last Trade Time Type Quantity Stock Price Currency
19:55:01 25 $ 1.8297 USD

Nektar Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
321.33M 183.62M - 90.12M -276.06M -1.50 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nektar Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NKTR Message Board. Create One! See More Posts on NKTR Message Board See More Message Board Posts

Historical NKTR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.741.871.481.591,360,0790.05082.92%
1 Month1.581.871.201.481,987,2250.210813.34%
3 Months0.721.870.63031.172,609,2151.07148.72%
6 Months0.501.870.41260.94973441,870,9541.29258.16%
1 Year0.79251.870.41260.82615123,283,3950.9983125.97%
3 Years20.1720.250.41263.812,745,432-18.38-91.12%
5 Years35.6936.850.41268.962,325,706-33.90-94.98%

Nektar Therapeutics Description

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.

Your Recent History

Delayed Upgrade Clock